Ryan Khouri, CEO of CTT Pharmaceutical Holdings Inc. (NASDAQ: CTTH), bought 9,000 shares on November 4, 2026, at $0.05 per share for a total of $450. Following the purchase, Khouri directly holds 9,452,536 shares. The stock currently trades at $0.06.
According to InvestingPro analysis, CTTH appears overvalued at current levels, trading at a Price/Book multiple of 86.81. The company has a market cap of $3.33 million.
CTT Pharmaceutical Holdings appointed Zhanna Kelley, CPA, as its new PCAOB auditor, replacing Holt & Patterson. The company stated in an SEC filing that Holt & Patterson's resignation was not due to disagreements regarding accounting practices or issues in the company's reports.